Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

SIBN

SI-BONE Inc

Dec 05 • 04:00PM ET

19.68

+0.44 2.29 %

Healthcare • Medical Devices • USA • NASD

Peers: GMED ATEC OFIX MDT SYK ZBH JNJ IART BAX BVS

| Held by: VTI IWM IWO VXF IHI SCHA VTWO IWC VHT XHE

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.51	Insider Own	10.87%	Shs Outstand	43.27M	Perf Week	1.13%
Market Cap	853.94M	Forward P/E	-	EPS next Y	-0.49	Insider Trans	-3.62%	Shs Float	38.68M	Perf Month	28.12%
Enterprise Value	745.04M	PEG	-	EPS next Q	-0.12	Inst Own	91.50%	Short Float	7.34%	Perf Quarter	22.01%
Income	-21.76M	P/S	4.41	EPS this Y	29.22%	Inst Trans	1.98%	Short Ratio	5.55	Perf Half Y	4.13%
Sales	193.58M	P/B	4.95	EPS next Y	7.51%	ROA	-9.43%	Short Interest	2.84M	Perf YTD	40.37%
Book/sh	3.98	P/C	5.86	EPS next 5Y	24.24%	ROE	-12.91%	52W High	20.05 -1.85%	Perf Year	51.15%
Cash/sh	3.36	P/FCF	-	EPS past 3/5Y	24.13% 13.67%	ROIC	-10.47%	52W Low	12.49 57.50%	Perf 3Y	60.26%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	22.86% 19.96%	Gross Margin	79.62%	Volatility	3.35% 4.82%	Perf 5Y	-15.03%
Dividend TTM	-	EV/Sales	3.85	EPS Y/Y TTM	43.90%	Oper. Margin	-13.10%	ATR (14)	0.75	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.62	Sales Y/Y TTM	23.27%	Profit Margin	-11.24%	RSI (14)	68.49	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	7.97	EPS Q/Q	32.93%	SMA20	6.41%	Beta	0.70	Target Price	25.22
Payout	-	Debt/Eq	0.21	Sales Q/Q	20.61%	SMA50	19.79%	Rel Volume	1.41	Prev Close	19.24
Employees	349	LT Debt/Eq	0.21	Earnings	Nov 10 AMC	SMA200	20.04%	Avg Volume	511.70K	Price	19.68
IPO	Oct 17, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	33.89% 4.30%	Trades		Volume	722,961	Change	2.29%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-06-24	Reiterated	Needham	Buy	$27 → $19
Mar-28-24	Initiated	Piper Sandler	Overweight	$25
Oct-12-22	Initiated	Jefferies	Buy	$20
Apr-07-22	Resumed	Cantor Fitzgerald	Overweight	$34
Jun-08-21	Initiated	Citigroup	Buy	$40
Mar-09-21	Reiterated	Needham	Buy	$35 → $34
Dec-16-20	Reiterated	Needham	Buy	$28 → $35
Aug-04-20	Reiterated	Needham	Buy	$22 → $24
Jun-16-20	Resumed	Cantor Fitzgerald	Overweight	$25
May-05-20	Reiterated	Needham	Buy	$27 → $22
Feb-19-20	Initiated	Needham	Buy	$27
Jan-08-20	Initiated	SunTrust	Buy	$27
Dec-18-19	Initiated	Cantor Fitzgerald	Overweight	$27
Nov-12-18	Initiated	Morgan Stanley	Overweight	$24
Nov-12-18	Initiated	JMP Securities	Mkt Outperform	$27
Nov-12-18	Initiated	Canaccord Genuity	Buy	$25
Nov-12-18	Initiated	BofA/Merrill	Buy	$23

Show Previous Ratings

Dec-05-25 09:55AM	Should You Buy Si-Bone (SIBN) After Golden Cross? (Zacks)
Nov-18-25 04:09PM	SI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025 (GlobeNewswire)
Nov-11-25 03:02PM	Why SI-Bone Stock Was Crushing It Today (Motley Fool) +16.20%
12:02AM	SI-BONE Inc (SIBN) Q3 2025 Earnings Call Highlights: Robust Revenue Growth and Strategic ... (GuruFocus.com)
Nov-10-25 05:30PM	Si-Bone (SIBN) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
04:34PM	Loading…
04:34PM	Si-Bone: Q3 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance (GlobeNewswire)
Nov-06-25 05:40PM	Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Nov-04-25 05:40PM	PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Beats Revenue Estimates (Zacks)
Oct-20-25 04:09PM	SI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025 (GlobeNewswire)
Aug-26-25 04:03PM	SI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025 (GlobeNewswire)
Aug-14-25 01:22PM	Synergy Spine Solutions Appoints Troy Wahlenmaier as Chief Commercial Officer (PR Newswire)
Aug-05-25 03:04AM	SI-BONE Inc (SIBN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Positive ... (GuruFocus.com) -10.61%
Aug-04-25 05:45PM	Si-Bone (SIBN) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
04:40PM	Si-Bone: Q2 Earnings Snapshot (Associated Press Finance)
04:09PM	Loading…
04:09PM	SI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 Guidance (GlobeNewswire)
Jul-30-25 05:45PM	Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Jul-29-25 04:30PM	SI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 (GlobeNewswire)
Jul-14-25 04:09PM	SI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025 (GlobeNewswire)
Jul-07-25 12:00PM	All You Need to Know About Si-Bone (SIBN) Rating Upgrade to Buy (Zacks)
Jun-04-25 04:30PM	SI-BONE to Truist Securities MedTech Conference on June 17, 2025 (GlobeNewswire)
04:30PM	SI-BONE to Present at Truist Securities MedTech Conference on June 17, 2025 (GlobeNewswire)
May-28-25 04:30PM	SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025 (GlobeNewswire)
May-26-25 09:55AM	Wall Street Analysts See a 34.22% Upside in Si-Bone (SIBN): Can the Stock Really Move This High? (Zacks)
May-14-25 07:30AM	4 Recent Earnings Winners Riding Fresh Momentum in May (MarketBeat)
May-13-25 12:00PM	What Makes Si-Bone (SIBN) a Strong Momentum Stock: Buy Now? (Zacks)
May-08-25 09:55AM	Wall Street Analysts Think Si-Bone (SIBN) Could Surge 41.21%: Read This Before Placing a Bet (Zacks)
May-06-25 04:09PM	SI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025 (GlobeNewswire) +15.44% +6.20%
08:35AM	Q1 2025 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents)
03:05AM	SI-BONE Inc (SIBN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Positive ... (GuruFocus.com)
05:20PM	Loading…
May-05-25 05:20PM	Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:27PM	Si-Bone: Q1 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 Guidance (GlobeNewswire)
May-02-25 09:29AM	SI-BONE Inc (SIBN) Q1 2025: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Apr-14-25 04:09PM	SI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025 (GlobeNewswire)
Apr-10-25 10:42AM	IQVIA (IQV) Moves 8.7% Higher: Will This Strength Last? (Zacks)
Apr-08-25 07:00PM	SI-BONE, Inc.: Small-cap Developer Of Medical Implants And A Steady Revenue Grower (Seeking Alpha) +6.58%
Feb-26-25 10:01AM	SI-Bone price target raised to $24 from $20 at Needham (TipRanks)
Feb-25-25 09:03AM	Q4 2024 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents) +5.55%
02:03AM	SI-BONE Inc (SIBN) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Positive EBITDA (GuruFocus.com)
Feb-24-25 05:40PM	Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:43PM	Si-Bone: Q4 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 Guidance (GlobeNewswire)
Feb-22-25 04:21PM	SI-BONE Inc (SIBN) Q4 2024: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Feb-21-25 08:00AM	Bruker Appoints Laura Francis to its Board of Directors (Business Wire)
Feb-17-25 10:00AM	Si-Bone (SIBN) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-03-25 04:09PM	SI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025 (GlobeNewswire) +5.29%
Jan-18-25 08:00AM	SI-Bone price target raised to $20 from $19 at Needham (TipRanks)
Jan-13-25 09:00AM	SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024 (GlobeNewswire) +18.29%
Dec-12-24 09:55AM	Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 64.71%: Here's is How to Trade (Zacks)
Nov-26-24 09:55AM	Wall Street Analysts See an 83.56% Upside in Si-Bone (SIBN): Can the Stock Really Move This High? (Zacks)
Nov-20-24 04:09PM	SI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024 (GlobeNewswire)
Nov-13-24 10:54AM	Q3 2024 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents) -15.93%
02:18AM	SI-BONE Inc (SIBN) Q3 2024 Earnings Call Highlights: Record Revenue and Path to Profitability (GuruFocus.com)
Nov-12-24 05:25PM	Si-Bone (SIBN) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:21PM	Si-Bone: Q3 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance (GlobeNewswire)
Nov-11-24 07:13AM	SI-BONE Inc (SIBN) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-05-24 08:30AM	SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite (GlobeNewswire) +6.75%
Oct-30-24 03:35AM	Strength Seen in Si-Bone (SIBN): Can Its 6.9% Jump Turn into More Strength? (Zacks)
Oct-22-24 04:09PM	SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024 (GlobeNewswire)
Oct-14-24 07:28AM	First patients are treated with Si-Bones pelvic fracture fixation device (Medical Device Network)
Oct-10-24 08:30AM	SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation (GlobeNewswire)
Aug-26-24 09:55AM	Wall Street Analysts Think Si-Bone (SIBN) Could Surge 40.3%: Read This Before Placing a Bet (Zacks)
08:19AM	SI-BONE (SIBN) Receives FDA Nod for Its TNT Implant System (Zacks)
Aug-22-24 04:30PM	SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024 (GlobeNewswire) +11.07%
Aug-20-24 08:30AM	SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System (GlobeNewswire)
Aug-08-24 09:55AM	Wall Street Analysts Believe Si-Bone (SIBN) Could Rally 64.45%: Here's is How to Trade (Zacks)
Aug-06-24 09:16AM	Q2 2024 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents)
08:30AM	SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024 (GlobeNewswire)
Aug-05-24 05:55PM	Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:55PM	Si-Bone: Q2 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024 (GlobeNewswire)
Jul-15-24 04:09PM	SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024 (GlobeNewswire) +8.92%
Jun-05-24 04:09PM	SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024 (GlobeNewswire)
May-07-24 11:16AM	SI-BONE, Inc. (NASDAQ:SIBN) Q1 2024 Earnings Call Transcript (Insider Monkey) +8.29%
09:00AM	SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures (GlobeNewswire)
08:04AM	Q1 2024 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents)
03:08AM	SI-BONE Inc (SIBN) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ... (GuruFocus.com)
May-06-24 05:25PM	Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:24PM	Si-Bone: Q1 Earnings Snapshot (Associated Press Finance)
04:09PM	SI-BONE, Inc. Reports Financial Results for the First Quarter 2024 (GlobeNewswire)
Apr-29-24 10:00AM	Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release (Zacks)
09:00AM	SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024 (GlobeNewswire)
Apr-15-24 04:09PM	SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024 (GlobeNewswire)
Mar-04-24 04:09PM	SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024 (GlobeNewswire)
Feb-27-24 06:49AM	Q4 2023 SI-BONE Inc Earnings Call (Thomson Reuters StreetEvents) -13.53%
Feb-26-24 05:38PM	Si-Bone: Q4 Earnings Snapshot (Associated Press Finance)
04:34PM	SI-BONE Inc (SIBN) Reports Record Revenue Growth in Q4 and Full Year 2023 (GuruFocus.com)
04:09PM	SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance (GlobeNewswire)
Feb-19-24 10:00AM	Si-Bone (SIBN) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release (Zacks)
Feb-05-24 04:09PM	SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024 (GlobeNewswire)
Jan-30-24 08:30AM	SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application (GlobeNewswire)
Jan-22-24 10:54AM	15 Small-Cap Stocks with High Potential (Insider Monkey)
Jan-08-24 08:30AM	SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023 (GlobeNewswire) -7.06%
Jan-05-24 09:02AM	SI-BONE Inc Director Davis Timothy E JR Sells 9,900 Shares (GuruFocus.com)
Nov-30-23 09:30AM	Si-Bone (SIBN) Crossed Above the 50-Day Moving Average: What That Means for Investors (Zacks)
Nov-21-23 07:03AM	Insider Sell: President, Commercial Ops Anthony Recupero Sells 8,457 Shares of SI-BONE Inc (SIBN) (GuruFocus.com)
Nov-14-23 04:09PM	SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023 (GlobeNewswire) +9.47%
Nov-07-23 11:08AM	SI-BONE, Inc. (NASDAQ:SIBN) Q3 2023 Earnings Call Transcript (Insider Monkey)

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PISETSKY MICHAEL A.	SVP, Ops & Adm/Chief Legal Ofr	Nov 24 '25	Sale	20.00	400	8,000	251,496	Nov 26 05:21 PM
Maheshwari Anshul	Chief Financial Officer	Nov 21 '25	Sale	20.01	1,200	24,016	203,873	Nov 25 06:02 PM
Maheshwari Anshul	Chief Financial Officer	Nov 25 '25	Sale	20.00	100	2,000	203,773	Nov 25 06:02 PM
MICHAEL PISETSKY SEPARATE PROP	Officer	Nov 21 '25	Proposed Sale	18.68	20,000	373,600		Nov 21 04:47 PM
ANSHUL MAHESHWARI	Officer	Nov 21 '25	Proposed Sale	18.68	19,842	370,649		Nov 21 04:47 PM
RECUPERO ANTHONY J	President, Commercial Ops	Nov 17 '25	Sale	17.44	3,833	66,832	268,144	Nov 19 07:05 PM
PISETSKY MICHAEL A.	SVP, Ops & Adm/Chief Legal Ofr	Nov 17 '25	Sale	17.41	3,328	57,934	251,896	Nov 19 07:04 PM
Maheshwari Anshul	Chief Financial Officer	Nov 17 '25	Sale	17.43	3,460	60,297	205,073	Nov 19 07:03 PM
FRANCIS LAURA	Chief Executive Officer	Nov 17 '25	Sale	17.43	11,341	197,622	408,363	Nov 19 07:02 PM
FRANCIS LAURA	Chief Executive Officer	Nov 18 '25	Sale	17.70	5,411	95,763	351,319	Nov 19 07:02 PM
DAVID & LAURA FRANCIS JOINT RE	Director	Nov 18 '25	Proposed Sale	17.92	5,411	96,965		Nov 18 04:21 PM
FRANCIS LAURA	Chief Executive Officer	Nov 11 '25	Sale	17.06	5,411	92,307	356,730	Nov 13 04:31 PM
DUNN JEFFREY W	Director	Nov 11 '25	Option Exercise	4.32	80,000	345,600	90,307	Nov 13 04:31 PM
DUNN JEFFREY W	Director	Nov 11 '25	Sale	18.95	80,000	1,516,000	10,307	Nov 13 04:31 PM
Maheshwari Anshul	Chief Financial Officer	Nov 11 '25	Sale	18.33	2,601	47,685	208,533	Nov 13 04:31 PM
DANIEL WOLF	Director	Nov 12 '25	Proposed Sale	18.03	14,402	259,691		Nov 12 04:57 PM
The Jeffrey W. Dunn Living Tru	Director	Nov 11 '25	Proposed Sale	15.68	80,000	1,254,400		Nov 12 07:06 AM
ANSHUL MAHESHWARI	Officer	Nov 11 '25	Proposed Sale	15.68	2,601	40,784		Nov 12 07:00 AM
DAVID & LAURA FRANCIS JOINT RE	Director	Nov 11 '25	Proposed Sale	15.68	5,411	84,844		Nov 12 06:54 AM
DUNN JEFFREY W	Director	Nov 03 '25	Sale	14.80	293	4,338	10,831	Nov 04 06:51 PM
PISETSKY MICHAEL A.	SVP, Ops & Adm/Chief Legal Ofr	Oct 02 '25	Sale	14.25	3,128	44,583	255,224	Oct 06 06:10 PM
Maheshwari Anshul	Chief Financial Officer	Oct 02 '25	Sale	14.20	3,311	47,013	211,134	Oct 06 06:10 PM
RECUPERO ANTHONY J	President, Commercial Ops	Oct 02 '25	Sale	14.25	3,311	47,197	271,977	Oct 06 06:09 PM
RECUPERO ANTHONY J	President, Commercial Ops	Aug 18 '25	Sale	15.62	3,833	59,875	275,288	Aug 20 05:35 PM
PISETSKY MICHAEL A.	SVP, Ops & Adm/Chief Legal Ofr	Aug 18 '25	Sale	15.64	3,329	52,055	258,352	Aug 20 05:35 PM
Maheshwari Anshul	Chief Financial Officer	Aug 18 '25	Sale	15.57	3,461	53,881	214,445	Aug 20 05:34 PM
FRANCIS LAURA	Chief Executive Officer	Aug 18 '25	Sale	15.60	11,343	176,940	419,704	Aug 20 05:31 PM
Freund John Gordon	Director	Aug 08 '25	Sale	15.99	12,132	193,998	91,767	Aug 11 06:09 PM
DUNN JEFFREY W	Director	Aug 04 '25	Sale	17.37	293	5,091	11,647	Aug 06 05:51 PM
FRANCIS LAURA	Chief Executive Officer	Jul 07 '25	Sale	18.26	757	13,823	362,141	Jul 07 08:31 PM
Maheshwari Anshul	Chief Financial Officer	Jul 02 '25	Sale	18.34	5,005	91,811	217,078	Jul 07 08:30 PM
RECUPERO ANTHONY J	President, Commercial Ops	Jul 02 '25	Sale	18.27	3,310	60,476	279,121	Jul 07 08:29 PM
PISETSKY MICHAEL A.	SVP, Ops & Adm/Chief Legal Ofr	Jul 02 '25	Sale	18.29	3,127	57,203	261,681	Jul 07 08:29 PM
DAVID & LAURA FRANCIS JOINT RE	Director	Jul 07 '25	Proposed Sale	18.47	757	13,982		Jul 07 04:14 PM
ANSHUL MAHESHWARI	Officer	Jul 03 '25	Proposed Sale	18.43	1,695	31,239		Jul 03 01:28 PM
DUNN JEFFREY W	Director	Jun 05 '25	Sale	19.05	3,377	64,335	17,354	Jun 06 07:48 PM
FRANCIS LAURA	Chief Executive Officer	May 16 '25	Sale	19.67	12,385	243,670	495,170	May 20 07:48 PM
FRANCIS LAURA	Chief Executive Officer	May 19 '25	Sale	19.49	5,412	105,464	490,987	May 20 07:48 PM
Maheshwari Anshul	Chief Financial Officer	May 16 '25	Sale	19.76	9,585	189,399	224,507	May 20 07:47 PM
Maheshwari Anshul	Chief Financial Officer	May 19 '25	Sale	19.48	2,424	47,213	222,083	May 20 07:47 PM
RECUPERO ANTHONY J	President, Commercial Ops	May 16 '25	Sale	19.56	4,147	81,109	282,015	May 20 07:46 PM
Pisetsky Michael A	SVP, Ops & Adm/Chief Legal Ofr	May 16 '25	Sale	19.66	3,459	68,006	264,636	May 20 07:45 PM
DAVID & LAURA FRANCIS JOINT RE	Director	May 19 '25	Proposed Sale	19.79	5,412	107,103		May 19 04:57 PM
ANSHUL MAHESHWARI	Officer	May 19 '25	Proposed Sale	19.79	2,424	47,971		May 19 04:57 PM
ANSHUL MAHESHWARI	Officer	May 16 '25	Proposed Sale	18.88	4,958	93,607		May 16 04:21 PM
Maheshwari Anshul	Chief Financial Officer	May 12 '25	Sale	19.02	4,937	93,926	232,069	May 14 08:33 PM
ANSHUL MAHESHWARI	Officer	May 12 '25	Proposed Sale	18.49	4,937	91,285		May 12 04:27 PM
FRANCIS LAURA	Chief Executive Officer	May 07 '25	Sale	17.18	38,504	661,368	302,958	May 09 07:01 PM
Maheshwari Anshul	Chief Financial Officer	May 08 '25	Sale	18.17	28,350	515,094	237,006	May 09 07:00 PM
Maheshwari Anshul	Chief Financial Officer	May 07 '25	Sale	17.00	4,937	83,939	265,356	May 09 07:00 PM
ANSHUL MAHESHWARI	Officer	May 08 '25	Proposed Sale	17.47	28,350	495,274		May 08 04:23 PM
ANSHUL MAHESHWARI	Officer	May 07 '25	Proposed Sale	16.45	4,937	81,214		May 07 04:21 PM
DAVID & LAURA FRANCIS JOINT RE	Officer	May 07 '25	Proposed Sale	16.45	38,504	633,391		May 07 04:21 PM
DUNN JEFFREY W	Director	May 01 '25	Sale	13.78	336	4,628	12,536	May 02 05:08 PM
Pisetsky Michael A	SVP, Ops & Adm/Chief Legal Ofr	Apr 30 '25	Option Exercise	4.68	21,367	99,998	266,245	May 02 05:07 PM
Pisetsky Michael A	SVP, Ops & Adm/Chief Legal Ofr	Apr 02 '25	Sale	14.14	3,128	44,219	244,878	Apr 04 05:14 PM
RECUPERO ANTHONY J	President, Commercial Ops	Apr 02 '25	Sale	14.15	3,311	46,853	284,555	Apr 04 05:13 PM
Maheshwari Anshul	Chief Financial Officer	Apr 02 '25	Sale	14.11	3,311	46,723	270,293	Apr 04 05:12 PM
FRANCIS LAURA	Chief Executive Officer	Feb 18 '25	Sale	17.22	46,233	795,915	506,761	Feb 21 04:19 PM
Maheshwari Anshul	Chief Financial Officer	Feb 18 '25	Sale	16.86	11,180	188,518	273,604	Feb 21 04:18 PM
RECUPERO ANTHONY J	President, Commercial Ops	Feb 18 '25	Sale	16.86	9,531	160,732	287,866	Feb 21 04:17 PM
DUNN JEFFREY W	Director	Feb 18 '25	Sale	16.77	1,619	27,152	15,191	Feb 21 04:16 PM
DUNN JEFFREY W	Director	Feb 03 '25	Sale	16.51	337	5,562	17,290	Feb 05 06:09 PM
RECUPERO ANTHONY J	President, Commercial Ops	Jan 02 '25	Sale	13.90	3,670	51,014	222,814	Jan 06 06:58 PM
Maheshwari Anshul	Chief Financial Officer	Jan 02 '25	Sale	13.91	5,304	73,802	189,319	Jan 06 06:56 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SIBN

SI-BONE Inc

Upgrade your FINVIZ experience